Sky Century Investment (SKYI) Receivables - Other (2013 - 2014)
Sky Century Investment (SKYI) reported Receivables - Other of $25830.0 for Q3 2014, up 31.12% year-over-year from $19700.0 in Q3 2013, and up 200.0% quarter-over-quarter from -$25830.0 in Q2 2014.
Sky Century Investment (SKYI) Receivables - Other (2013 - 2014) Analysis & Trends
Sky Century Investment (SKYI) has 2 years of Receivables - Other data on file, last reported at $25830.0 in Q3 2014.
- Receivables - Other for Q3 2014 came in at $25830.0, up 31.12% year-over-year; the trailing twelve-month figure through Aug 2014 was $25830.0 (up 31.12% YoY), and the FY2014 annual result was -$31765.0, down 129.42% from the prior year.
- Receivables - Other grew to $25830.0 in Q3 2014 per SKYI's latest filing, from -$25830.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $25830.0 in Q3 2014 and troughed at -$25830.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sky Century Investment | - | - | 31,666.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2014 | 25,830.00 |
| Aug 31, 2014 | 25,830.00 |
| May 31, 2014 | -25,830.00 |
| May 31, 2014 | -25,830.00 |
| Feb 28, 2014 | 24,700.00 |
| Feb 28, 2014 | 24,700.00 |
| Nov 30, 2013 | 24,700.00 |
| Nov 30, 2013 | 24,700.00 |
| Aug 31, 2013 | 19,700.00 |
| Aug 31, 2013 | 19,700.00 |
| May 31, 2013 | -13,846.00 |
| May 31, 2013 | -13,846.00 |